REFERENCES
- Abernethey, R. J. et al. 1967. Pentagastrin as a stimulant of maximal gastric acid response in man. A multicentre pilot study. Lancet 1, 291–295.
- Bachrach, W. H. 1958. Anticholinergic drugs. Survey of the literature and some experimental observations. Amer. J. dig. Dis. 3, 743–799.
- Berkowitz, D. 1956. The effect of a long-acting preparation (spansule) of belladonna alkaloide on gastric secretion of patients with peptic ulcer. Gastroenterology 30, 608–612.
- Blair, E. L., Harper, A. A., Lake, H. J. & Reed, J. D. 1961. The effect of atropine upon gastrin-stimulated gastric secretion. J. Physiol. (Lond.) 159, 72–73.
- Emâs, S., Billings, A. & Grossman, M. I. 1968. Effects of gastrin and pentagastrin on gastric and pancreatic secretion in dogs. Scand. J. Gastroent. 3, 234–240.
- Gill, B. F. & Jesup, J. S. 1950. The effect of atropine on certain gastric functions in patients with duodenal ulcers Gastroenterology 15, 736–746.
- Gregory, R. A. & Tracy, H. J. 1961. The preparation and properties of gastrin. J. Physiol. (Lond.) 156, 523–543.
- Hirschowitz, B. I. 1967. The control of pepsinogen secretion. Ann. N.Y. Acad. Sci. 140, 709–723.
- Hirschowitz, B. I., London, J. L. & Pollard, H. M. 1957. Histamine stimulation of gastric pepsin secretion in man. Gastroenterology 32, 85–87.
- Hunt, J. N. 1948. A method of estimating peptic activity in gastric contents. J. biol. Chem. 177, 751–766.
- Juniper, K. 1967. The relative effect of an anticholinergic drug, glycopyrrolate, on basal secretion and sweat and salivary-gland activity. Amer. J. dig. Dis. 12, 439–448.
- Komarov, S. A. 1942. Studies on gastrin: II. Physiological properties of the specific gastric sccretagogue of the pyloric mucuos membrane. Rev. Canad. Biol. 2, 377–401.
- Konturek, S. J. 1967. Gastrin-like pentapeptide ICI 50123. A potent gastric stimulant in man. Amer. J. dig. Dis. 12, 285–292.
- Konturek, S. J. & Oleksy, J. 1969. The effect of cholinergic and adrenergic blockage on basal and pentagastrin-induced acid secretion. Scand. J. Gastroent. 4, 13–16.
- Konturek, S. J., Oleksy, J. & Wysocki, A. 1968. Effect of atropine on gastric acid response to graded doses of pentagastrin and histamine in duodenal ulcer patients before and after vagotomy. Amer. J. dig. Dis. 13, 792–800.
- Lambert, R., Martin, F. & Vagne, M. 1968. Relationships between hydrogen ion and pepsin concentration in human gastric secretion. Digestion 1, 65–77.
- Makhlouf, G. M., McManus, J. P. A. & Knill, J. R. 1968. Quantitative aspects of synergism and inhibition of gastric acid secretion. Gastroenterology 54, 532–537.
- Makhlouf, G. M., Moore, E. W. & Blum, A. L. 1968. Models for the ‘secretion’ of pepsin and other proteins by the human stomach. Gastroenterology 55, 457–464.
- Mason, M. C., Giles, G. R. & Clark, C. G. 1969. Continuous intravenous pentagastrin as a stimulant of maximal gastric acid secretion. Gut 10, 34–38.
- Piper, D. W. 1967. Antacid and anticholinergic drug therapy of peptic ulcer. Gastroenterology 52, 1009–1018.
- Sun, D. C. H. & Shay, H. 1956. Optimal effective dose of anticholinergic drug in peptic ulcer therapy. Amer. J. dig. Dis. 11, 421–431.
- Walan, A. 1969. The effect of 1-hyoscyamine on gastric secretion of acid and pepsin in man. Scand. J. Gastroent. 4, 157–167.
- Wormsley, K. G. & Mahoney, M. P. 1967. Parietal cell responsiveness in duodenal ulcer. Brit. med. J. 1, 278.